Lower Risk of Cardiovascular Events in Postmenopausal Women Taking Oral Estradiol Compared With Oral Conjugated Equine Estrogens — Nicholas L. Smith (2013) | RDL Network
Lower Risk of Cardiovascular Events in Postmenopausal Women Taking Oral Estradiol Compared With Oral Conjugated Equine Estrogens
JAMA Internal Medicine 174(1): 25-25
Article 2013 English
Authors
NS
Nicholas L. Smith
MB
Marc Blondon
KW
Kerri L. Wiggins
Abstract
1 min read
Little is known about the comparative cardiovascular safety of oral hormone therapy products, which impedes women from making informed safety decisions about hormone therapy to treat menopausal symptoms.
Nicholas L. Smith, Susan R. Heckbert, Rozenn N. Lemaître, Alex P. Reiner, Thomas Lumley, Noel S. Weiss, Eric B. Larson, Frits R. Rosendaal, Bruce M. Psaty
Mary Cushman, Joseph C. Larson, Frits R. Rosendaal, Susan R. Heckbert, J. David Curb, Lawrence S. Phillips, Alison E. Baird, Charles B. Eaton, Randall S. Stafford
Research and Practice in Thrombosis and Haemostasis
Nicholas L. Smith, Susan R. Heckbert, Carine J.M. Doggen, Rozenn N. Lemaître, Alex P. Reiner, Thomas Lumley, Joost C.M. Meijers, Bruce M. Psaty, Frits R. Rosendaal
.jpg){kind=small}
Discussion(0)
No comments yet. Be the first to comment.